Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer

NCT01155791 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Urologic Neoplasms
Prostate Cancer
Prostate Cancer Metastatic Disease

Interventions

DRUG: Docetaxel
DRUG: Biosyn
DRUG: Prednisone

Sponsor

Sandy Srinivas